288 related articles for article (PubMed ID: 10618007)
1. Cholinesterase inhibitors: A new class of psychotropic compounds.
Cummings JL
Am J Psychiatry; 2000 Jan; 157(1):4-15. PubMed ID: 10618007
[TBL] [Abstract][Full Text] [Related]
2. Assessment of treatment-associated changes in behavior and cholinergic therapy of neuropsychiatric symptoms in Alzheimer's disease.
Cummings JL; Masterman DL
J Clin Psychiatry; 1998; 59 Suppl 13():23-30. PubMed ID: 9771827
[TBL] [Abstract][Full Text] [Related]
3. Acetylcholinesterase inhibitors, neuropsychiatric symptoms, and Alzheimer's disease subtypes: an alternate hypothesis to global cognitive enhancement.
Brousseau G; Rourke BP; Burke B
Exp Clin Psychopharmacol; 2007 Dec; 15(6):546-54. PubMed ID: 18179307
[TBL] [Abstract][Full Text] [Related]
4. Cholinesterase inhibitor therapies and neuropsychiatric manifestations of Alzheimer's disease.
Wynn ZJ; Cummings JL
Dement Geriatr Cogn Disord; 2004; 17(1-2):100-8. PubMed ID: 14564129
[TBL] [Abstract][Full Text] [Related]
5. Revisiting the cholinergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer's type.
Pinto T; Lanctôt KL; Herrmann N
Ageing Res Rev; 2011 Sep; 10(4):404-12. PubMed ID: 21292041
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease: cognitive and behavioral pharmacotherapy.
Cummings JL; Mendez MF
Conn Med; 1997 Sep; 61(9):543-52. PubMed ID: 9334509
[TBL] [Abstract][Full Text] [Related]
7. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
Beier MT
Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
[TBL] [Abstract][Full Text] [Related]
8. The cerebrovascular role of the cholinergic neural system in Alzheimer's disease.
Van Beek AH; Claassen JA
Behav Brain Res; 2011 Aug; 221(2):537-42. PubMed ID: 20060023
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychiatric symptoms and cholinergic therapy for Alzheimer's disease.
Levy ML; Cummings JL; Kahn-Rose R
Gerontology; 1999; 45 Suppl 1():15-22. PubMed ID: 9876214
[TBL] [Abstract][Full Text] [Related]
10. Do acetylcholinesterase inhibitors boost synaptic scaling in Alzheimer's disease?
Small DH
Trends Neurosci; 2004 May; 27(5):245-9. PubMed ID: 15111005
[TBL] [Abstract][Full Text] [Related]
11. Manipulation of the cholinergic system.
Geroldi C; Bianchetti A; Trabucchi M
Funct Neurol; 1997; 12(3-4):187-91. PubMed ID: 9218975
[No Abstract] [Full Text] [Related]
12. [Drug therapy of Alzheimer's disease].
Sulkava R
Duodecim; 2000; 116(24):2867-73. PubMed ID: 12077892
[No Abstract] [Full Text] [Related]
13. Treating apathy in Alzheimer's disease.
Boyle PA; Malloy PF
Dement Geriatr Cogn Disord; 2004; 17(1-2):91-9. PubMed ID: 14564128
[TBL] [Abstract][Full Text] [Related]
14. [Cholinergic deficiency syndrome as an indicator for the cholinesterase inhibitors].
Lemstra AW; Eikelenboom P; van Gool WA
Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2201-3. PubMed ID: 14640055
[TBL] [Abstract][Full Text] [Related]
15. Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action.
Jentsch JD; Roth RH; Taylor JR
Prog Brain Res; 2000; 126():433-53. PubMed ID: 11105661
[TBL] [Abstract][Full Text] [Related]
16. Innovations: geriatric psychiatry: diagnosis and treatment of neuropsychiatric symptoms in Alzheimer's disease.
Lavretsky H; Nguyen LH
Psychiatr Serv; 2006 May; 57(5):617-9. PubMed ID: 16675752
[TBL] [Abstract][Full Text] [Related]
17. [Acetylcholinesterase inhibitors in Alzheimer's disease: further comments on their mechanisms of action and therapeutic consequences].
Nieoullon A
Psychol Neuropsychiatr Vieil; 2010 Jun; 8(2):123-31. PubMed ID: 20525543
[TBL] [Abstract][Full Text] [Related]
18. Beyond the cholinergic hypothesis: the effect of metrifonate and other cholinesterase inhibitors on neuropsychiatric symptoms in Alzheimer's disease.
Kaufer D
Dement Geriatr Cogn Disord; 1998; 9 Suppl 2():8-14. PubMed ID: 9718229
[TBL] [Abstract][Full Text] [Related]
19. Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia: review of neuropsychiatric impairment in Alzheimer's disease.
Grossberg GT
Curr Med Res Opin; 2005 Oct; 21(10):1631-9. PubMed ID: 16238903
[TBL] [Abstract][Full Text] [Related]
20. Psychopharmacology of noncognitive abnormal behaviors in Alzheimer's disease.
Raskind MA
J Clin Psychiatry; 1998; 59 Suppl 9():28-32. PubMed ID: 9720484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
